FDA
label_change
· 2021-12-09
FDA Approved: SODIUM OXYBATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
Summary
FDA approved a supplemental application for Sodium Oxybate (Hikma Pharmaceuticals USA Inc.), resulting in changes to the product's labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SODIUM OXYBATE (SODIUM OXYBATE)